Tanner G. DeHart, Ph.D.

Tanner is a microbiologist and biochemist who applies his experience to assist clients in the prosecution of patents in the life sciences industry.

As an undergraduate and graduate researcher at Virginia Tech, Tanner studied Borrelia burgdorferi, the causative agent of Lyme disease. He developed a new high-resolution liquid chromatography-tandem mass spectrometry method that allowed him to identify the first known alteration to glycan strand organization in bacterial peptidoglycan and characterize its importance to the physiology of B. burgdorferi using biochemical and physiological techniques. His work contributed significantly to patents for the detection, targeting, and therapeutic intervention of Lyme disease-related pathologies.

Tanner’s doctoral research at Harvard Medical School utilized classical, modern, and next-generation molecular, genetic, and biochemical approaches to investigate the coordination of the metabolic pathways responsible for the synthesis of the bacterial cell envelope.

He has authored and co-authored peer-reviewed research articles published in Nature Microbiology, Molecular Microbiology, and Public Library of Science Pathogens.